Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic [Homozigot ailevi hiperkolesterolemili hastalarin uzun dönem izlemi: Bir üniversite hastanesi lipit poliklini?inin 13 yillik deneyimi]
Küçük Resim Yok
Tarih
2014
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Turkish Society of Cardiology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Objectives: Familiar hypercholesterolemia (FH) is a genetic disease characterized with extremely high levels of cholesterol leading to premature atherosclerosis. In homozygous individuals (HoFH) cardiovascular events could develop in childhood. In this article, long-term clinical experience with adult HoFH patients who are followed in Department of Cardiology, Ege University Faculty of Medicine is presented. Study design: Seventeen HoFH patients (11 females, 6 males) who are being followed between the years 2000-2013 were included. All data including clinical characteristics, family history, lipid levels, treatment, lipid-apheresis, cardiovascular events, complications were obtained retrospectively from patient chart records. Results: Mean age was 31 ±10 years at admission to our clinic. First diagnosis age was 25±14. At diagnosis, mean cholesterol level was 625±136 mg/dl. Admission complaints were dermatologic (41 %) and ischemic symptoms (41 %). Atotal of 3 patients (18%) were diagnosed during family screening. 65% of the patients' parents had consanguineous marriage. Xantomas was present in 59%, aortic valve pathology in 59%, and carotid artery plaques in 47%. Coronary artery disease was documented in 59%. Though all patients had indication for apheresis, 10 patients received apheresis due to high refusal rate. Age at the first apheresis was 27±12 (minimum 10-maximum 42) and adherence to apheresis was 60%. With 2 years regular apheresis skin depositions were vanished, however carotid atherosclerosis and aortic pathology progressed. During the 43±42 months follow-up, 4 patients died (mean age: 25±5). Conclusion: Diagnosis is late in HoAH. Due to the delayed treatment of lipid apheresis, atherosclerosis and aortic stenosis progress in these patients. The awareness of the physicians and knowledge of the public is warranted. © 2014 Turkish Society of Cardiology.
Açıklama
Anahtar Kelimeler
Apolipoprotein B-100/genetics, Coronary artery disease, Familial hypercholesterolemia, Genetic predisposition to disease, Hyperlipoproteinemia type 11/epidemiology, Lipid apheresis, Xanthoma
Kaynak
Turk Kardiyoloji Dernegi Arsivi
WoS Q Değeri
Scopus Q Değeri
Q4
Cilt
42
Sayı
7
